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country, screening programs have yielded more patients
in early stages, leading to improved results after surgery
[7].
The people in Iceland used to be at high risk of gastric
cancer [1,5,8,9], but the incidence has declined steadily
during the past five decades. Gastric cancer ranked first
and second in the group of most frequent cancer types
in Icelandic males and females, respectively [10], but a
steady decrease in incidence for both sexes has been
seen during the past 50 years. The incidence for males
has declined from 77 to 15 cases per 100 000 between
1955 and 1999, whereas the incidence has declined from
32 to 6 per 100 000 for females during the same time
period (Fig. 1). Information on cancer cases in Iceland is
obtained from the Icelandic Cancer Registry, which has
been in operation since 1954; the information on cancer
incidence in Iceland is, therefore, likely to be nearly
complete for 1955 and onwards for cancer at all sites.
When compared with other common cancer types
(Fig. 1), the reduction in gastric cancer incidence is
unique, as a reciprocal trend is found for other common
cancer types, in both males (i.e., prostate, lung, and
colon; Fig. 1a) and females (i.e., breast, lung, and colon;
Fig. 1b). While the reasons for this decline in gastric
cancer incidence are not clear, the world-wide geo-
graphic differences (Table 1) [2]; the coincidence of the
decline with socioeconomic improvement and changes
in diet and food preservation; and the role of H. pylori
infection [2] all suggest that environmental factors
underlie these trends. Gastric cancer incidence in Ice-
land is compared with rates in countries in South and
North America, Europe, and Asia in Table 1. In this
context, Iceland is now a country of intermediate
incidence, but it was clearly a high-risk nation in the
1950s. The reduction in incidence probably represents a
combination of lower incidence and better healthcare
during the past 50 years.
Earlier studies showed considerable geographic
variation in gastric cancer incidence within Iceland
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Gastric cancer incidence varies substantially within
Europe [1,2]. Incidences within the highest risk popula-
tions (30 per 100000 age-adjusted [world population]
in males from Eastern Europe) are similar to those seen
in Japan. Low-risk populations (10 per 100000) have
incidences similar to those for Caucasians in the United
States. Consistent with the general worldwide pattern,
the overall incidence in nearly all European countries,
including Iceland, has been declining for several de-
cades, and this is thought to be due to the combination
of an improved diet and a reduced prevalence of
Helicobacter pylori infection [1–3]. The mortality from
this disease is generally high. About half the cases seen
in the Western world [4] and Iceland are resectable
[5,6], where the chance of cure for those resected is
approximately 35% [6]. The mortality is related to the
stage of the disease, and, in Japan, a high-incidence
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[10,11], and this led to the belief that the high incidence
was related to a diet rich in pickle-salted, smoked,
and singed food. An excess of gastric cancer was found
among farmers and was found to correlate well with the
consumption of home-smoked and home-grilled food in
rural areas. In many of these homemade products, the
content of nitrites and nitrates was higher than that
considered safe for human consumption [10]. The di-
etary habits of Icelanders have changed considerably
during the past 50 years, and the smoked and salted
food is now more a traditional delicacy consumed on
special occasions, and it has largely been replaced by
fresh and frozen products. This change in dietary habits
is probably another of the factors that can help to ex-
plain the decrease in the incidence of gastric cancer in
Iceland.
In Icelandic males during the period 1955–1984,
78.1% of all gastric cancers were intestinal type, and
16.5% were diffuse type; in Icelandic females, 73.1%
were intestinal type and 20.7% were diffuse type [10].
There has been a more pronounced change in incidence
of the intestinal type (Laurèn), as the decline during
the past five decades (i.e., 1955–1999) in gastric cancer
in Icelanders has mostly affected the intestinal type of
tumor, whereas diffuse-type tumors have declined only
slightly in both sexes (Fig. 2) [5,10]. Based on this pat-
tern, it has been suggested that the major determinants
of the intestinal gastric cancer type are environmental
rather than genetic [10]. This pattern is also found in
Table 1. Age-adjusted (world population) gastric cancer mortality rates in Iceland and in selected countries by sex (rates
per/100000 population)
Argentina United States Japan United Kingdom Norway Iceland Iceland
1996 1996 1996 1996 1996 1957 1996
Men 11.6 5.2 30.5 9.3 9.0 77.1 9.6
Women 4.9 2.3 12.2 3.6 4.1 24.0 5.5
Source: WHO Cancer mortality database, 2001 [25]
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Fig. 1a,b. Changes in the incidence of common cancers in
Icelandic a males and b females during the period 1955–1999;
data from the Icelandic Cancer Registry
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Fig. 2a,b. Changes in the incidence of intestinal-type and
diffuse-type gastric cancer in Icelandic a males and b females
in the period 1960–1989
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Fig. 3. Location of gastric cancer tumors
in Iceland and four other countries/
regions during the period 1980–1990
[26–29]
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other high-risk countries [3,12]. Diet and infection with
H. pylori are probably the prominent environmental
risk factors for gastric cancer, but familial aggregation,
in a variable but significant proportion of cases, suggests
the importance of genetic predisposition [3,13,14]. This
has been supported by reports of a dominantly inherited
predisposition to gastric cancer [3,15–18] and, subse-
quently, the description of germline mutation in the
E-cadherin/CDH1 gene in Maori kindreds with heredi-
tary, early onset, diffuse-type gastric cancer [19]. In a
recent study [20], the genetic epidemiological aspects of
gastric cancer in Iceland were investigated. It was found
that first-degree relatives of gastric cancer patients have
a two- to three fold increased risk of developing gastric
cancer compared with the general population. The
risk is elevated for both sexes, although the eleva-
tion is greater for males. Signs of a histological spe-
cific risk were found, as relatives of those probands
diagnosed with the diffuse type were at higher risk
compared with relatives of those probands diagnosed
with the intestinal type. Overall, it was suggested that
genealogical and familial aggregation information
might have important prospective value for the relatives
of gastric cancer patients.
In Iceland, most gastric cancers are located in the
distal stomach (antrum/pylorus), followed by the middle
and the proximal stomach (cardia/fundus) (Fig. 3). A
similar pattern is found in the Netherlands, but in Japan
and Bavaria (Germany), tumors are most common in
the middle stomach, and in the United States they are
most common in the proximal stomach. The different
location patterns may have relevance for gastric cancer
patients, as the prevalence of H. pylori infection is
higher in patients with the cancer located distally than in
those with the cancer located proximally [21]. Also, a
study from Japan [22] indicates that the familial gastric
cancers are frequently located in the cardiac region
(proximal) and that they appear to be more aggressive
than sporadic gastric cancers (in general, proximal can-
cers have a worse prognosis). In Iceland, H. pylori was
detected in 80% of patients with gastric cancer, and
there was significant decrease in IgG antibody levels
over a period of several years before the diagnosis
[23]. In a recent review [24], a weak association was
found between H. pylori and gastric cancer, but the
association was much lower than that needed to account
for the sharp variations in gastric cancer mortality be-
tween different populations (e.g., 20-fold higher in cer-
tain parts of China than in the United States [24]) or
between past and present (e.g., eight fold decrease in
Iceland between 1957 and 1996; Table 1). This observa-
tion implies that important cause(s) of gastric cancer still
await discovery.
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